Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors (vol 12, 2016, 2021)

被引:4
|
作者
Iketani, Sho
Forouhar, Farhad
Liu, Hengrui
Hong, Seo Jung
Lin, Fang-Yu
Nair, Manoj S.
Zask, Arie
Huang, Yaoxing
Xing, Li
Stockwell, Brent R.
Chavez, Alejandro
Ho, David D.
机构
[1] Aaron Diamond AIDS Research Center, Columbia University Irving Medical Center, New York, NY
[2] Department of Microbiology and Immunology, Columbia University Irving Medical Center, New York, NY
[3] Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, NY
[4] Department of Chemistry, Columbia University, New York, NY
[5] Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY
[6] WuXi AppTec, Cambridge, MA
[7] Department of Biological Sciences, Columbia University, New York, NY
基金
美国国家卫生研究院;
关键词
D O I
10.1038/s41467-021-23082-3
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
We report the identification of three structurally diverse compounds – compound 4, GC376, and MAC-5576 – as inhibitors of the SARS-CoV-2 3CL protease. Structures of each of these compounds in complex with the protease revealed strategies for further development, as well as general principles for designing SARS-CoV-2 3CL protease inhibitors. These compounds may therefore serve as leads for the basis of building effective SARS-CoV-2 3CL protease inhibitors. © 2021, The Author(s).
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Author Correction: Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors
    Sho Iketani
    Farhad Forouhar
    Hengrui Liu
    Seo Jung Hong
    Fang-Yu Lin
    Manoj S. Nair
    Arie Zask
    Yaoxing Huang
    Li Xing
    Brent R. Stockwell
    Alejandro Chavez
    David D. Ho
    Nature Communications, 12
  • [2] Peptidomimetic nitrile warheads as SARS-CoV-2 3CL protease inhibitors
    Bai, Bing
    Arutyunova, Elena
    Khan, Muhammad Bashir
    Lu, Jimmy
    Joyce, Michael A.
    Saffran, Holly A.
    Shields, Justin A.
    Kandadai, Appan Srinivas
    Belovodskiy, Alexandr
    Hena, Mostofa
    Vuong, Wayne
    Lamer, Tess
    Young, Howard S.
    Vederas, John C.
    Tyrrell, D. Lorne
    Lemieux, M. Joanne
    Nieman, James A.
    RSC MEDICINAL CHEMISTRY, 2021, 12 (10): : 1722 - 1730
  • [3] In silico screening of potential compounds from begonia genus as 3CL protease (3Cl pro) SARS-CoV-2 inhibitors
    Maulana, Saipul
    Wahyuni, Tutik Sri
    Widiyanti, Prihartini
    Zubair, Muhammad Sulaiman
    JOURNAL OF PUBLIC HEALTH IN AFRICA, 2023, 14
  • [4] The Interaction of Antiviral Drugs with SARS-Cov-2 3CL Protease
    Saadh, Mohamed J.
    JOURNAL OF PHARMACEUTICAL NEGATIVE RESULTS, 2022, 13 (03) : 865 - 868
  • [5] Inhibition of the 3CL Protease and SARS-CoV-2 Replication by Dalcetrapib
    Niesor, Eric J.
    Boivin, Guy
    Rheaume, Eric
    Shi, Rong
    Lavoie, Veronique
    Goyette, Nathalie
    Picard, Marie-Eve
    Perez, Anne
    Laghrissi-Thode, Fouzia
    Tardif, Jean-Claude
    ACS OMEGA, 2021, 6 (25): : 16584 - 16591
  • [6] Design and synthesis of isatin derivatives as effective SARS-CoV-2 3CL protease inhibitors
    Bao, Hong-Lei
    Tu, Gao
    Yue, Qiu
    Liu, Pei
    Zheng, Hui-Li
    Yao, Xiao-Jun
    CHEMICAL BIOLOGY & DRUG DESIGN, 2023, 102 (04) : 857 - 869
  • [7] Identification of pyrogallol as a warhead in design of covalent inhibitors for the SARS-CoV-2 3CL protease
    Haixia Su
    Sheng Yao
    Wenfeng Zhao
    Yumin Zhang
    Jia Liu
    Qiang Shao
    Qingxing Wang
    Minjun Li
    Hang Xie
    Weijuan Shang
    Changqiang Ke
    Lu Feng
    Xiangrui Jiang
    Jingshan Shen
    Gengfu Xiao
    Hualiang Jiang
    Leike Zhang
    Yang Ye
    Yechun Xu
    Nature Communications, 12
  • [8] Identification of pyrogallol as a warhead in design of covalent inhibitors for the SARS-CoV-2 3CL protease
    Su, Haixia
    Yao, Sheng
    Zhao, Wenfeng
    Zhang, Yumin
    Liu, Jia
    Shao, Qiang
    Wang, Qingxing
    Li, Minjun
    Xie, Hang
    Shang, Weijuan
    Ke, Changqiang
    Feng, Lu
    Jiang, Xiangrui
    Shen, Jingshan
    Xiao, Gengfu
    Jiang, Hualiang
    Zhang, Leike
    Ye, Yang
    Xu, Yechun
    NATURE COMMUNICATIONS, 2021, 12 (01)
  • [9] An Integrated Computational and Experimental Approach to Identifying Inhibitors for SARS-CoV-2 3CL Protease
    Zhai, Tianhua
    Zhang, Fangyuan
    Haider, Shozeb
    Kraut, Daniel
    Huang, Zuyi
    FRONTIERS IN MOLECULAR BIOSCIENCES, 2021, 8
  • [10] Synergistic Effects of Natural Compounds Toward Inhibition of SARS-CoV-2 3CL Protease
    Mishra, Avinash
    Khan, Wajihul Hasan
    Rathore, Anurag S.
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2021, 61 (11) : 5708 - 5718